Immediate Impact

34 standout
Sub-graph 1 of 12

Citing Papers

Cancer statistics, 2025
2025 Standout
Breast cancer: pathogenesis and treatments
2025 Standout
2 intermediate papers

Works of Erik Asmus being referenced

Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab
2020
Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
2020

Author Peers

Author Last Decade Papers Cites
Erik Asmus 93 38 36 53 41 9 168
Talia Mitchell 24 41 39 26 30 6 149
Enza Di Felice 142 68 13 92 17 12 274
Ornella Nicoletto 69 41 34 11 43 15 179
Ilka Petry 49 11 44 12 18 9 154
Asad Haider 64 39 33 14 142 10 276
T.C. Kok 202 82 57 17 20 12 281
Ricardo Delgado 80 72 13 91 12 9 274
L. Morales 119 40 45 17 12 10 177
Ludovica Grassi 40 16 54 51 18 9 161
Petra Jankowska 34 24 14 30 21 6 136

All Works

Loading papers...

Rankless by CCL
2026